iPS Academia Japan, Inc.

Sharing the fruits of iPS cell research
for the good of all humanity

Japanese

Therapeutic Use License

Standard Financial Terms for Non-Exclusive Worldwide License

(Patents to be licensed: AJ001, AJ002, AJ005, AJ006, AJ018 and AJ066)

Fees and Royalties SSE *1 Non-SSE
Upfront fee US$13,000 US$60,000
Annual maintenance fee
(until NDA approval)
US$12,000 US$25,000
Milestone payments on first IND
applications in each of 3 areas *2
(in total of 3 areas)
US$41,000
(in total of 3 areas)
US$130,000
Milestone payments on first NDA
applications in each of 3 areas *2
(in total of 3 areas)
US$250,000
(in total of 3 areas)
US$295,000
Milestone payment on achievement
of sales total US$100M
US$400,000
Milestone payment on achievement
of sales total US$500M
US$700,000
Running royalties 1.5% of sales of final products
Annual minimum royalties
(after NDA approval)
US$20,000 US$25,000
  • *1 A small and startup entity (SSE) means an entity which (i) has been within 10 years from its foundation, (ii) employs 50 or fewer people, and (iii) has received US$20M or less in total as financial resources.
  • *2 3 areas mean North America, Europe and the rest of the world.

Different conditions depending on cell types, etc.
Please ask us for more information.